>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
基于生物信息学分析的卵巢癌中miR-4324调控机制的研究
作者:眭怡群  张永胜 
单位:苏州大学附属第二医院 病理科, 江苏 苏州 215004
关键词:卵巢癌 微小RNA-4324 生物信息学 
分类号:R737.31
出版年·卷·期(页码):2021·40·第四期(421-426)
摘要:

目的:利用生物信息学研究微小RNA-4324(miR-4324)在卵巢癌中的表达情况,进一步分析miR-4324在卵巢癌发生、发展中的作用。方法:采用GEO数据库及GEO2R在线工具分析miR-4324在卵巢癌中的表达水平。用TargetScan数据库预测miR-4324的靶基因(TG-miR4324),并与从GEO数据库中筛选出的卵巢癌差异表达基因(DEGs)取交集,获得miR-4324相关性差异靶基因。运用DAVID数据库进行GO及KEGG富集分析,STRING数据库构建蛋白互作(PPI)网络,Cytoscape筛选hub基因,Kaplan-Meier Plotter分析hub基因对预后的影响。结果:卵巢癌组织中miR-4324表达下调。获得TG-miR4324共5 292个,其中筛选出290个miR-4324相关性差异靶基因,主要在细胞外基质、细胞黏附性、细胞外基质(ECM)受体的相互作用及癌症相关通路中富集。从miR-4324相关性差异靶基因中筛选出8个hub基因,其中SPSB1、TGOLN2等6个基因表达与卵巢癌患者的总生存期(OS)相关。结论:miR-4324在卵巢癌中表达下调,miR-4324相关性差异靶基因在卵巢癌生物学过程中起重要作用。

Objective: To investigate the expression of microRNA-4324(miR-4324) in ovarian cancer using bioinformatics and to explore its role in the genesis and development of ovarian cancer. Methods: GEO database and GEO2R were used to screen the expression of miR-4324 between normal ovarian tissues and ovarian cancers. Target genes of miR-4324(TG-miR4324) were predicted by TargetScan database. Then, we selected the overlapped genes between differentially expressed genes(DEGs) obtained from GEO database and TG-miR4324.GO and KEGG pathway enrichment analysis were performed on these genes. STRING and Cytoscape were used to construct a protein-protein interaction(PPI) network, and the prognostic effects of hub genes were presented by Kaplan-Meier Plotter. Results: The expression of miR-4324 was down-regulated in ovarian cancer.Five thousand two hundred and ninety-two predicted target genes were identified for miR-4324.Subsequently,two hundred and ninety genes overlapped in TG-miR4324 and DEGs were selected for GO and KEGG pathway enrichment analysis. These genes were significantly enriched in extracellular matrix, cellular adhesion, ECM receptor interaction and pathways in the cancer.Six hub genes including SPSB1 and TGOLN2 were significantly associated with the prognosis of patients with ovarian cancer. Conclusion: The expression of miR-4324 is down-regulated in ovarian cancer. Target genes of miR-4324 play an important role in the biological process of ovarian cancer.

参考文献:

[1] BARTELD P.MicroRNAs:genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2):281-297.
[2] LI H L, ZHU G L, XING Y W, et al. miR-4324 functions as a tumor suppressor in colorectal cancer by targeting HOXB2[J]. J Int Med Res, 2020, 48(3):1219683283.
[3] INAMOTO T, UEHARA H, AKAO Ycet al. A panel of microRNA signature as a tool for predicting survival of patients with urothelial carcinoma of the bladder[J]. Dis Markers, 2018, 2018:5468672.
[4] 陈军莹, 姚德生, 贺婵娟, 等.宫颈鳞癌MicroRNA差异表达的研究[J]. 实用医学杂志, 2014, 30(1):83-87.
[5] SZKLARCZYK D, GABLE A L, LYON D, et al. STRING v11:protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets[J]. Nucleic Acids Res, 2019, 47(D1):D607-D613.
[6] SMOOT M E, ONO K, RUSCHEINSKI J, et al. Cytoscape 2.8:new features for data integration and network visualization[J]. Bioinformatics, 2011, 27(3):431-432.
[7] XU Z, ZHOU Y, CAO Y, et al. Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis[J]. Med Oncol, 2016, 33(11):130.
[8] LI S, HANG L, MA Y, et al. Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients[J]. J Cell Mol Med, 2016, 20(12):2259-2268.
[9] ZHOU J, ZHU J, JIANG G, et al. Downregulation of microRNA-4324 promotes the EMT of esophageal squamous-cell carcinoma cells via upregulating FAK[J]. Onco Targets Ther, 2019, 12:4595-4604.
[10] WANG D Y, GENDOO D M A, BEN-DAVID Y, et al. A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling[J]. Breast Cancer Res, 2019, 21(1):18.
[11] LIU S, NHEU T, LUWOR R, et al. SPSB1, a novel negative regulator of the transforming growth factor-β signaling pathway targeting the type Ⅱ receptor[J]. J Biol Chem, 2015, 290(29):17894-17908.
[12] LIU S, IARIA J, SIMPSON R J, et al. Ras enhances TGF-β signaling by decreasing cellular protein levels of its type Ⅱ receptor negative regulator SPSB1[J]. Cell Commun Signal, 2018, 16(1):10.
[13] FENG Y, PAN T C, PANT D K, et al. SPSB1 promotes breast cancer recurrence by potentiating c-MET signaling[J]. Cancer Discov, 2014, 4(7):790-803.
[14] KIM H J, KIM M K, BAE M K, et al. SPSB1 enhances ovarian cancer cell survival by destabilizing p21[J]. Biochem Biophys Res Commun, 2019, 510(3):364-369.
[15] YOUNG A R, CHAN E Y, HU X W, et al. Starvation and ULK1-dependent cycling of mammalian Atg9 between the TGN and endosomes[J]. J Cell Sci, 2006, 119(Pt 18):3888-3900.
[16] KIHARA A, KABEYA Y, OHSUMI Y, et al. Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network[J]. EMBO Rep, 2001, 2(4):330-335.
[17] 任松森, 吴松, 程萍.Beclin1通过调控自噬水平对卵巢癌细胞顺铂的敏感性干预效果及机制研究[J]. 中国性科学, 2020, 29(1):48-52.
[18] ZHANG S F, WANG X Y, FU Z Q, et al. TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer[J]. Autophagy, 2015, 11(2):225-238.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 307414 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-87232481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364